Breaking News Instant updates and real-time market news.

ADI

Analog Devices

$110.28

-2.72 (-2.41%)

, MXIM

Maxim Integrated

$52.18

-1.86 (-3.44%)

07:38
08/15/19
08/15
07:38
08/15/19
07:38

Analog Devices estimates cut at Stifel following peer guidance

Ahead of Analog Devices' (ADI) Q3 earnings report on August 21, Stifel analyst Tore Svanberg lowered his estimates for calendar 2019 and 2020 revenue to account for the fact that guidance from peers Maxim Integrated (MXIM), NXP Semiconductors (NXPI) and Texas Instruments (TXN) were lower than expected by an average of 571 basis points. The analyst, who expects relatively in-line July quarter results but a softer October quarter outlook from Analog Devices, trimmed his price target on the stock to $125 from $127 to account for his lowered estimates, but maintains a Buy rating.

ADI

Analog Devices

$110.28

-2.72 (-2.41%)

MXIM

Maxim Integrated

$52.18

-1.86 (-3.44%)

NXPI

NXP Semiconductors

$100.01

-2.23 (-2.18%)

TXN

Texas Instruments

$120.59

-2.76 (-2.24%)

  • 21

    Aug

  • 10

    Sep

ADI Analog Devices
$110.28

-2.72 (-2.41%)

07/10/19
JEFF
07/10/19
NO CHANGE
JEFF
Texas Instruments, Analog Devices 'ownable' for next 4 cycles, says Jefferies
Jefferies analyst Mark Lipacis says shares of Analog Devices (ADI) and Texas Instruments (TXN) are "ownable" through the next four cycles. The analyst updated his "Analog Renaissance Report" and believes consolidation is "better and faster" than previously thought and that his three-to-five year earnings bull case is 50%/100% above 2019 consensus estimates.
07/09/19
PIPR
07/09/19
NO CHANGE
Target $135
PIPR
Overweight
Analog Devices price target raised to $135 from $118 at Piper Jaffray
Piper Jaffray analyst Harsh Kumar raised his price target for Analog Devices to $135 from $118 and reiterates an Overweight rating on the shares after hosting investor meetings with management. The analyst believes the company is executing very well in the current environment. Management believes inventory levels are healthy across the board, with China distribution channels largely flushed out, Kumar tells investors in a research note. In addition, Analog Devices sees major 5G deployments driving growth in 2020, the analyst adds. Kumar continues to believe Analog Devices is a "best-in-class" semiconductor company.
06/12/19
MSCO
06/12/19
UPGRADE
Target $114
MSCO
Overweight
Morgan Stanley upgrades NXP Semiconductors to Overweight on relative value
As previously reported, Morgan Stanley analyst Craig Hettenbach upgraded NXP Semiconductors (NXPI) to Overweight from Equal Weight as he sees relative value in the stock after the shares have underperformed peers by 73% during the last three years. While peers such as Analog Devices (ADI), ON Semiconductor (ON), Maxim Integrated (MXIM) and Cypress Semiconductor (CY) have inventory levels at the high end or even above targets, NXP's inventory in distribution has stayed flat and is just below the mid-point of its target, said Hettenbach. As NXP's business recovers, he likes the company's ability to constrain spending to get it back in line with its target and drive operating margin, the analyst added. He also noted that the stock's multiple is at the biggest discount to peers in its history. Hettenbach raised his price target NXP shares to $114 from $99, but recommends an opportunistic approach when adding to positions given the ongoing risks of the current semiconductor cycle.
06/10/19
06/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tesla (TSLA) upgraded to Buy from Neutral at Roth Capital with analyst Craig Irwin saying while he believes rising battery costs are likely to be a 2019 margin headwind, demand from China will likely be stronger than most anticipate, reducing the potential for lowered 2019 unit guidance. 2. Analog Devices (ADI) double upgraded to Buy from Sell at Goldman Sachs with analyst Toshiya Hari saying he is turning more bullish on the company as he believes analog units are tracking below trend. 3. United Technologies (UTX) upgraded to Buy from Neutral at Seaport Global with analyst Josh Sullivan saying at first glance, the company's merger-of-equals with Raytheon (RTN) offers a "compelling combination" in large defense and commercial aerospace growth verticals. 4. Adecoagro (AGRO) upgraded to Buy from Neutral at Citi with analyst Fernanda Perez Da Cunha citing the improvement in commodity prices and a slight reduction in long term maintenance capital expenditures for sugar and ethanol for the upgrade. 5. Sirius XM (SIRI) upgraded to Outperform from Neutral at Credit Suisse with analyst Brian Russo saying the stock decline has brought an attractive risk/reward opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MXIM Maxim Integrated
$52.18

-1.86 (-3.44%)

08/01/19
BNCH
08/01/19
INITIATION
BNCH
Hold
Maxim Integrated initiated with a Hold at Benchmark
Benchmark analyst Ruben Roy initiated Maxim Integrated with a Hold rating, stating that he appreciates the company's product and customer transformation, but he believes shares are fairly valued and already reflect the company's strong execution.
06/10/19
MSCO
06/10/19
NO CHANGE
MSCO
Morgan Stanley cuts estimates for Intel, others with Huawei exposure
Morgan Stanley analyst Joseph Moore lowered his estimates and cut his price target for Intel (INTC) and four other chipmakers that supply Huawei as he thinks it is becoming clear the situation involving the U.S. and the Chinese company will extend "at least beyond quarter end." Moore lowered his price target on Intel shares to $61 from $63, cut his target for Xilinx (XLNX) to $126 from $137, trimmed his target for Maxim Integrated (MXIM) to $50 from $51, edged down his Western Digital (WDC) target to $46 from $47 and lowered his Amphenol (APH) target to $108 from $110.
08/01/19
08/01/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. AMD (AMD) and Maxim Integrated (MXIM) initiated with a Hold at Benchmark. 2. Amag Pharmaceuticals (AMAG) and Cassava Sciences (SAVA) initiated with a Buy at H.C. Wainwright. 3. Crispr Therapeutics (CRSP) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
NXPI NXP Semiconductors
$100.01

-2.23 (-2.18%)

07/30/19
OPCO
07/30/19
NO CHANGE
OPCO
Perform
NXP Semiconductors visibility poor amid semi cycle correction, says Oppenheimer
Oppenheimer analyst Rick Schafer said NXP Semiconductors' visibility remains constrained by geopolitical tensions and macro uncertainty, particularly in China, noting that management said they still see a stronger second half, though less so than originally hoped. Given that macro uncertainty remains high and visibility is "poor," as well as the fact that the stock is up 42% year-to-date, Schafer said he sees the risk/reward as balanced in the near-term and keeps a Perform rating on NXP shares.
07/29/19
07/29/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ericsson (ERIC) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Alexander Duval citing his view that its fundamentals are solid in Networks, Digital Services and Managed Services but the stock has pulled back by about 5% relative to the others in EU Tech since the company's Q2 report on July 17. 2. AB InBev (BUD) upgraded to Buy from Neutral at BofA/Merrill with analyst Fernando Ferreira saying the cycle of downward earnings revisions is coming to an end. 3. Volaris (VLRS) upgraded to Overweight from Equal Weight at Barclays with analyst Pablo Monsivais saying he sees share upside given the company's "simple model" that drives the lowest possible costs. 4. NXP Semiconductors (NXPI) upgraded to Outperform from In Line at Evercore ISI. 5. Gilead (GILD) upgraded to Top Pick from Outperform at RBC Capital with analyst Brian Abrahams saying the stock represents a "compelling opportunity" with limited downside risks as the company's HIV franchise generates a "steady" annual revenue of about $16B per year over the medium term given the "very strong" uptake of its Biktarvy, according to prescription data. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/29/19
EVER
07/29/19
UPGRADE
Target $125
EVER
Outperform
NXP Semiconductors upgraded to Outperform from In Line at Evercore ISI
Evercore ISI analyst CJ Muse upgraded NXP Semiconductors to Outperform from In Line and raised his price target for the shares to $125 from $110.
07/24/19
RHCO
07/24/19
NO CHANGE
Target $133
RHCO
Hold
Texas Instruments price target raised to $133 from $122 at SunTrust
SunTrust analyst William Stein raised his price target on Texas Instruments (TXN) to $133 after its Q2 earnings beat, but kept his Hold rating, saying bottom in fundamentals for semiconductor names is being extended to Q3 from Q2. The analyst also contends that the recovery in Texas Instruments is "mostly priced in", favoring semi sector stocks that have recently underperformed such as NXP Semi (NXPI), Microchip (MCHP), and Broadcom (AVGO).
TXN Texas Instruments
$120.59

-2.76 (-2.24%)

07/24/19
OPCO
07/24/19
NO CHANGE
Target $130
OPCO
Outperform
Texas Instruments price target raised to $130 from $120 at Oppenheimer
Oppenheimer analyst Rick Schafer raised his price target for Texas Instruments to $130 from $120 following quarterly results. The analyst reiterates an Outperform rating on the shares.
07/24/19
FBCO
07/24/19
NO CHANGE
Target $140
FBCO
Outperform
Texas Instruments price target raised to $140 from $130 at Credit Suisse
Credit Suisse analyst John Pitzer raised his price target for Texas Instruments to $140 form $130 following quarterly results. The analyst reiterates an Outperform rating on the shares.
07/24/19
LOOP
07/24/19
NO CHANGE
Target $140
LOOP
Buy
Texas Instruments price target raised to $140 from $126 at Loop Capital
Loop Capital analyst Cody Acree raised his price target on Texas Instruments to $140 and kept his Buy rating after the company's "solid upside" reported in Q2 along with a "more steady and constructive tone" conveyed by its management in the earnings call. The analyst says that in the prior earnings call, Texas Instruments was "more dour" about the "broad based" semiconductor weakness and limited visibility along with the uncertainty related to U.S.-China trade. Acree sees the stock as well positioned to manage the industry correction cycle and return to sector growth.
07/24/19
BMOC
07/24/19
NO CHANGE
Target $150
BMOC
Outperform
Texas Instruments price target raised to $150 from $130 at BMO Capital
BMO Capital analyst Ambrish Srivastava raised his price target on Texas Instruments to $150 and kept his Outperform rating after its Q2 earnings beat that was driven by lower operating expense and better gross margins. The analyst also raises his FY19 and FY20 EPS forecasts by 33c and 17c to $5.37 and $6.17 respectively, saying he sees "meaningfully higher free cash flows and earnings potential" as the company's 300mm manufacturing footprint continues to grow.

TODAY'S FREE FLY STORIES

CBS

CBS

$43.83

0.5 (1.15%)

, VIA

Viacom

$27.27

-0.4 (-1.45%)

08:03
08/17/19
08/17
08:03
08/17/19
08:03
Periodicals
Viacom-CBS merger got panned by investors, Barron's says »

CBS (CBS) and Viacom…

CBS

CBS

$43.83

0.5 (1.15%)

VIA

Viacom

$27.27

-0.4 (-1.45%)

VIAB

Viacom

$26.02

0.09 (0.35%)

AAPL

Apple

$206.44

4.71 (2.33%)

DIS

Disney

$135.19

1.79 (1.34%)

T

AT&T

$34.98

0.64 (1.86%)

CMCSA

Comcast

$43.17

0.82 (1.94%)

CMCSK

Comcast

$0.00

(0.00%)

NFLX

Netflix

$302.74

6.81 (2.30%)

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

  • 23

    Sep

  • 23

    Oct

  • 27

    Oct

MYGN

Myriad Genetics

$25.36

2.14 (9.22%)

07:57
08/17/19
08/17
07:57
08/17/19
07:57
Periodicals
Myriad Genetics stock might have an FDA issue, Barron's says »

Myriad Genetics plunged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CSCO

Cisco

$46.96

0.73 (1.58%)

, NTAP

NetApp

$46.75

0.33 (0.71%)

07:50
08/17/19
08/17
07:50
08/17/19
07:50
Periodicals
Trade war hitting tech stocks, Barron's says »

Cisco (CSCO) plunged 9% a…

CSCO

Cisco

$46.96

0.73 (1.58%)

NTAP

NetApp

$46.75

0.33 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

  • 10

    Oct

  • 13

    Nov

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

, RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

07:47
08/17/19
08/17
07:47
08/17/19
07:47
Periodicals
Investors should not abandon oil, gas stocks, Barron's says »

Energy stocks have rarely…

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

BP

BP

$36.27

0.22 (0.61%)

XOM

Exxon Mobil

$68.30

1.06 (1.58%)

CVX

Chevron

$115.79

0.08 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 25

    Sep

TGT

Target

$84.20

1.67 (2.02%)

, WMT

Walmart

$112.99

0.32 (0.28%)

07:40
08/17/19
08/17
07:40
08/17/19
07:40
Periodicals
Grocery Outlet thriving as rivals struggle, Barron's says »

While Dow was down 800…

TGT

Target

$84.20

1.67 (2.02%)

WMT

Walmart

$112.99

0.32 (0.28%)

GO

Grocery Outlet

$46.55

2.81 (6.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

AEO

American Eagle

$15.40

0.63 (4.27%)

07:33
08/17/19
08/17
07:33
08/17/19
07:33
Periodicals
American Eagle to soar despite trade war, Barron's says »

American Eagle's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 25

    Sep

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

, MTCH

Match Group

$84.53

2.08 (2.52%)

07:27
08/17/19
08/17
07:27
08/17/19
07:27
Periodicals
Dating business might be IAC's best asset, greatest challenge, Barron's says »

IAC (IAC) has rallied 34%…

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

MTCH

Match Group

$84.53

2.08 (2.52%)

IAC

IAC

$249.17

4.21 (1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 10

    Sep

  • 10

    Oct

AAPL

Apple

$206.44

4.71 (2.33%)

, HAS

Hasbro

$114.29

1.13 (1.00%)

07:13
08/17/19
08/17
07:13
08/17/19
07:13
On The Fly
Week in review How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$206.44

4.71 (2.33%)

HAS

Hasbro

$114.29

1.13 (1.00%)

MAT

Mattel

$10.74

(0.00%)

AGR

Avangrid

$49.29

0.37 (0.76%)

JPM

JPMorgan

$107.73

2.52 (2.40%)

BAC

Bank of America

$27.04

0.79 (3.01%)

C

Citi

$63.46

2.13 (3.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 09

    Sep

  • 02

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 27

    Oct

NCLH

Norwegian Cruise Line

$50.48

1.38 (2.81%)

18:04
08/16/19
08/16
18:04
08/16/19
18:04
Hot Stocks
Norwegian Cruise Line CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RM

Regional Management

$27.12

0.14 (0.52%)

18:01
08/16/19
08/16
18:01
08/16/19
18:01
Hot Stocks
Regional Management CFO buys 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

RTN

Raytheon

$178.10

-0.42 (-0.24%)

17:59
08/16/19
08/16
17:59
08/16/19
17:59
Hot Stocks
Raytheon awarded $199.59M Navy contract for MK 15 CIWS »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$19.94

0.16 (0.81%)

17:57
08/16/19
08/16
17:57
08/16/19
17:57
Hot Stocks
Breaking Hot Stocks news story on Wendy's »

Trian Fund lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BRY

Berry Petroleum

$8.59

0.39 (4.76%)

17:54
08/16/19
08/16
17:54
08/16/19
17:54
Syndicate
Breaking Syndicate news story on Berry Petroleum »

Berry Petroleum files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSWI

CSW Industrials

$70.20

1.92 (2.81%)

17:52
08/16/19
08/16
17:52
08/16/19
17:52
Hot Stocks
CSW Industrials CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$3.03

0.135 (4.66%)

17:49
08/16/19
08/16
17:49
08/16/19
17:49
Hot Stocks
Oasis Petroleum CEO buys 30K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EE

El Paso Electric

$66.41

0.005 (0.01%)

17:45
08/16/19
08/16
17:45
08/16/19
17:45
Hot Stocks
El Paso Electric director Wertheimer sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$165.07

2.81 (1.73%)

17:42
08/16/19
08/16
17:42
08/16/19
17:42
Hot Stocks
Honeywell CEO sells 7.1K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.08

0.01 (0.93%)

17:37
08/16/19
08/16
17:37
08/16/19
17:37
Earnings
Moleculin Biotech reports Q2 EPS (3c), two estimates (10c) »

CFO Jonathan Foster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$0.13

0.0046 (3.59%)

17:35
08/16/19
08/16
17:35
08/16/19
17:35
Syndicate
Breaking Syndicate news story on Viveve »

Viveve files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGO

Perrigo

$46.21

0.535 (1.17%)

17:30
08/16/19
08/16
17:30
08/16/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Perrigo »

Starboard lowers Perrigo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

UAL

United Continental

$82.96

1.36 (1.67%)

17:28
08/16/19
08/16
17:28
08/16/19
17:28
Hot Stocks
United Continental director Shapiro buys 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

  • 23

    Sep

MBIO

Mustang Bio

$3.88

0.19 (5.15%)

17:26
08/16/19
08/16
17:26
08/16/19
17:26
Syndicate
Breaking Syndicate news story on Mustang Bio »

Mustang Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

BCLI

BrainStorm

$3.63

0.055 (1.54%)

17:24
08/16/19
08/16
17:24
08/16/19
17:24
Syndicate
Breaking Syndicate news story on BrainStorm »

BrainStorm files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLK

Westlake Chemical

$61.27

0.66 (1.09%)

17:15
08/16/19
08/16
17:15
08/16/19
17:15
Hot Stocks
Westlake Chemical raises quarterly dividend by 5% to 26.25c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIG

GigCapital

$10.30

(0.00%)

17:10
08/16/19
08/16
17:10
08/16/19
17:10
Hot Stocks
GigCapital receives noncompliance notice from NYSE »

GigCapital announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.